| Literature DB >> 30627362 |
Zahra Oskouei1, Maryam Akaberi2, Hossein Hosseinzadeh3,1.
Abstract
OBJECTIVES: Black cumin (Nigella sativa) belonging to Ranunculaceae family has a long history of medicinal use in various folk and traditional systems of medicine, including Iranian traditional medicine (ITM). These valuable medicinal seeds have been used traditionally against a variety of diseases such as dyspepsia, diabetes, headache, influenza and asthma. In addition, several scientific investigations have reported the therapeutic properties of N. sativa and thymoquinone (TQ), one of the most important constituent of black cumin, for treatment of a large number of diseases, including ischemia. As there is no comprehensive review study about the anti-ischemic activity of black cumin and its mechanism of action, in the current study, we aimed to review the anti-ischemic activities of N. sativa and TQ in different organ-related disorders.Entities:
Keywords: Black cumin; Brain; Cardiovascular; Ischemia; Nigella sativa
Year: 2018 PMID: 30627362 PMCID: PMC6312681 DOI: 10.22038/ijbms.2018.31703.7630
Source DB: PubMed Journal: Iran J Basic Med Sci ISSN: 2008-3866 Impact factor: 2.699
Figure 1The chemical structure of thymoquinone (TQ) and a schematic diagram of the pharmacological activities of Nigella sativa and TQ
Figure 2Protective effects of Nigella sativa against ischemia in different organs
Anti-ischemic activity of Nigella sativa and its active constitute TQ on different organs
|
|
|
|
| |
|---|---|---|---|---|
|
| Five N.G Wister albino rats i.p administration | Reduction in MDA and elevation in thiol (SH) | ( | |
|
| Wister rats (N=30), (1, 10, and 50 mg/kg, i.p) | Prevent intracellular edema of interneurons in 50 mg/kg group significantly compared to the sham group | ( | |
|
| TQ (2.5, 5 and 10 mg/kg) and | Dose-dependent reduction in the free radical-mediated lipid peroxidation as indicated by a decrease in the MDA levels | ( | |
|
| Wistar albino rats, 0.3 ml gastric tube | Significant reduction in serum and tissue MDA, NO and PCC and subsequent elevation in anti-oxidant power | ( | |
| Rats, 150-300 mg/kg, i.p | Dose-dependent reduction in | ( | ||
|
| Wister rats, Aqueous extract (0.7, 1 and 1.6 g/kg) ethanol extract (0.7, 1 and 1.6 g/kg) and TQ (2.5, 5 and 10 mg/kg, i.p.) | No significant effect on the radical-mediated lipid peroxidation (aqueous extract) | ( | |
| Wister-albino rats, TQ (5, 20, and 50 mg/kg) | A decrease in plasma ALT, AST, and LDH levels | ( | ||
|
| Wistar albino rats (n=44), TQ (10 mg/kg, i.p) | A significant decrease in infarct size | ( | |
| Wistar rats (20 mg/kg orally) | No significant change in biochemical and histological parameters | ( | ||
|
| Rats, TQ (50 mg/kg i.p.) | Dose-dependent reduction in MDA | ( | |
|
| Rats, aqueous extract (1, 1.5 and 2 mg/kg), ethanol extracts (1.6, 2.4 and 3.2 g/kg, i.p.) | Decrease in MDA level, | ( | |